- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
NIH Director Calls for 'Second Scientific Revolution' Amid COVID Skepticism
Dr. Jay Bhattacharya outlines vision for shifting scientific metrics at MAHA Institute event.
Published on Feb. 9, 2026
Got story updates? Submit your updates here. ›
The newly appointed director of the National Institutes of Health (NIH), Dr. Jay Bhattacharya, recently participated in an event hosted by the MAHA Institute, a group gaining political influence, where he outlined a vision for a 'second scientific revolution.' The event featured discussions questioning the safety of COVID-19 vaccines, exploring the possibility of a lab leak origin for the virus, and advocating for research into alternative treatments. Dr. Bhattacharya used the event to articulate his vision for a fundamental shift in the scientific process, including moving away from metrics like published papers and towards reproducibility of findings.
Why it matters
Dr. Bhattacharya's appointment as NIH director and his views on the COVID-19 pandemic response have drawn scrutiny. His engagement with the MAHA Institute, which has faced criticism for undermining its own health aims, highlights a growing tension between established scientific norms and a rising tide of skepticism, particularly in the wake of the COVID-19 crisis.
The details
The MAHA Institute event featured discussions questioning the safety of COVID-19 vaccines, exploring the possibility of a lab leak origin for the virus, and advocating for research into alternative treatments. A speaker who openly stated he and his family had not been vaccinated against COVID-19 received enthusiastic applause. A portion of the afternoon was dedicated to a presentation about a satirical film portraying Dr. Anthony Fauci negatively and downplaying the efficacy of vaccines, with the filmmaker seeking funding.
- Dr. Bhattacharya assumed his role as the 18th director of the NIH in April 2025.
- Dr. Bhattacharya's appointment was made by President Donald Trump and confirmed by the Senate on March 25, 2025.
The players
Dr. Jay Bhattacharya
The newly appointed director of the National Institutes of Health (NIH) who previously served as a professor of medicine, economics, and health research policy at Stanford University.
MAHA Institute
A group gaining political influence that hosted the event where Dr. Bhattacharya outlined his vision for a 'second scientific revolution.'
Dr. Anthony Fauci
The director of the National Institute of Allergy and Infectious Diseases who was the subject of a satirical film portrayed negatively at the MAHA Institute event.
What they’re saying
“Rather than using the metrics of how many papers are we publishing as a metric for success, instead, what we'll look at as a metric for successful scientific idea is 'do you have an idea where other people [who are] looking at the same idea tend to find the same thing as you?'”
— Dr. Jay Bhattacharya, Director, National Institutes of Health (newsdirectory3.com)
What’s next
As Dr. Bhattacharya settles into his role at the NIH, his vision for a 'second scientific revolution' and his engagement with groups like the MAHA Institute will likely continue to be subjects of debate and scrutiny within the scientific community and beyond.
The takeaway
Dr. Bhattacharya's proposed 'second scientific revolution' highlights a growing tension between established scientific norms and a rising tide of skepticism, particularly in the wake of the COVID-19 pandemic. His engagement with the MAHA Institute, which has faced criticism, underscores the complex dynamics at play as the new NIH director seeks to reshape the scientific process.


